Bothamley GH, et al. - This survey is designed to examine how recommendations for multidrug and extensively drug-resistant tuberculosis (M/XDR-TB) management are being implemented. In high incidence countries, infection control for inpatients with M/XDR-TB remains a problem. Here rifampicin resistance is frequently detected. However, further drug resistance develops due to the significant delay in tests to plan regimens tailored to the drug susceptibilities of the strain of Mycobacterium tuberculosis.